Cargando…
Beneficial Effects of Limosilactobacillus fermentum CECT 5716 Administration to Infants Delivered by Cesarean Section
Cesarean section (CS) disrupts the natural microbiota colonization process in infants, which might compromise immune system maturation, leading to a higher risk of infections. We evaluated the effect of the probiotic Limosilactobacillus (L.) fermentum CECT 5716 on the incidence of gastrointestinal a...
Autores principales: | Blanco-Rojo, Ruth, Maldonado, José, Schaubeck, Monika, Özen, Metehan, López-Huertas, Eduardo, Olivares, Mónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301023/ https://www.ncbi.nlm.nih.gov/pubmed/35874592 http://dx.doi.org/10.3389/fped.2022.906924 |
Ejemplares similares
-
Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk
por: Ozen, Metehan, et al.
Publicado: (2023) -
Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights
por: Rodríguez-Sojo, María Jesús, et al.
Publicado: (2021) -
Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis
por: Pastor-Villaescusa, Belén, et al.
Publicado: (2021) -
Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial
por: Hurtado, José A., et al.
Publicado: (2017) -
Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial
por: Maldonado, J., et al.
Publicado: (2019)